98-32892. Integrated Risk Information System (IRIS); Announcement of 1999 Program; Request for Information  

  • [Federal Register Volume 63, Number 237 (Thursday, December 10, 1998)]
    [Notices]
    [Pages 68285-68287]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-32892]
    
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    
    [FRL-6200-3]
    
    
    Integrated Risk Information System (IRIS); Announcement of 1999 
    Program; Request for Information
    
    AGENCY: Environmental Protection Agency.
    
    ACTION: Notice; Announcement of IRIS 1999 Program and request for 
    scientific information on chronic health effects of chemical 
    substances.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Integrated Risk Information System (IRIS) is an EPA data 
    base that contains EPA scientific consensus positions on potential 
    human health effects from environmental contaminants. On January 2, 
    1998 EPA announced the 1998 IRIS agenda and solicited scientific 
    information from the public for consideration in assessing the chronic 
    health effects of a list of chemical substances (63 FR 75). Most of the 
    assessments listed are complete or near completion, and EPA is 
    preparing a new set of chemical health assessments for IRIS. This 
    Notice describes the Agency's plans, and solicits scientific data and 
    evaluations for consideration in EPA's new assessments.
    
    DATES: Please submit information in response to this Notice by February 
    12, 1999.
    
    
    [[Page 68286]]
    
    
    ADDRESSES: Please send relevant scientific information to the IRIS 
    Submission Desk in accordance with the instructions provided under 
    ``Submission of Information'' in this Notice.
    
    FOR FURTHER INFORMATION: For information on the IRIS program, contact 
    Amy Mills, National Center for Environmental Assessment (mail code 
    8601D), U.S. Environmental Protection Agency, 401 M St. SW, Washington, 
    DC 20460, or call (202) 564-3204, or send electronic mail inquiries to 
    mills.amy@epa.gov. For general questions about access to IRIS, the 
    content of IRIS, or how to submit information in response to this 
    Notice, please call the Risk Information Hotline at (513) 569-7254.
    
    SUPPLEMENTARY INFORMATION:
    
    Background
    
        IRIS is an EPA data base containing Agency consensus scientific 
    positions on potential adverse human health effects that may result 
    from chronic (or lifetime) exposure to environmental contaminants. IRIS 
    currently provides health effects information on over 500 specific 
    chemical substances.
        IRIS contains chemical-specific summaries of qualitative and 
    quantitative health information in support of the first two steps of 
    the risk assessment process, i.e., hazard identification and dose-
    response evaluation. IRIS information includes the reference dose for 
    non-cancer health effects resulting from oral exposure, the reference 
    concentration for non-cancer health effects resulting from inhalation 
    exposure, and the carcinogen assessment for both oral and inhalation 
    exposure. Combined with specific situational exposure assessment 
    information, the summary health hazard information in IRIS may be used 
    as a source in evaluating potential public health risks from 
    environmental contaminants.
    
    The IRIS Program
    
        EPA completed the IRIS Pilot Program, which focused on improving 
    the scientific consensus and review process that precedes IRIS data 
    base entries. A set of chemical assessments were developed (or updated, 
    for existing entries) for IRIS utilizing the pilot process. This 
    process has been adopted for the post-Pilot program and consists of, 
    (1) an annual Federal Register announcement of EPA's IRIS agenda and 
    call for scientific information from the public on the selected 
    chemical substances, (2) a search of the current literature, (3) 
    development of health assessments and draft IRIS summaries, (4) peer 
    review within EPA, (5) peer review outside EPA, (6) EPA consensus 
    review and management approval, (7) preparation of final IRIS summaries 
    and supporting documents, and (8) entry of summaries and supporting 
    documents into the IRIS data base.
    
    Assessments Completed in FY 1998
    
        The following assessments were completed and entered into IRIS in 
    FY 1998 and early FY 1999. These assessments were announced in the 
    Federal Register notice of January 2, 1998. All health endpoints, 
    cancer and non-cancer, were assessed unless otherwise noted. Where 
    information was available, oral reference doses, inhalation reference 
    concentrations, and cancer unit risks and slope factors were developed.
    
    ------------------------------------------------------------------------
                       Name                               CAS No.
    ------------------------------------------------------------------------
    Arsenic [text added in carcinogenicity     7440-38-2
     section].
    Barium...................................  7440-39-3
    Bentazon.................................  25057-89-0
    Benzene [inhalation cancer assessment]...  71-43-2
    Beryllium................................  7440-41-7
    Chlordane................................  12789-03-6
    Chromium (III )..........................  16065-83-1
    Chromium (VI)............................  18540-29-9
    Methyl methacrylate......................  80-62-6
    Methylene diphenyl diisocyanate..........  101-68-8
    Naphthalene..............................  91-20-3
    ------------------------------------------------------------------------
    
    Assessments in Progress--Completion Planned for FY 1999 or FY 2000
    
        The following assessments are underway or generally complete, and 
    are planned for entry into IRIS in FY 1999 or FY 2000. These 
    assessments were announced in the January 2, 1998 Federal Register 
    notice. All health endpoints, cancer and non-cancer, are being assessed 
    unless otherwise noted. Where information is available, oral reference 
    doses, inhalation reference concentrations, cancer unit risks and slope 
    factors are being developed.
    
    ------------------------------------------------------------------------
                       Name                               CAS No.
    ------------------------------------------------------------------------
    Acetonitrile.............................  75-05-8
    Benzene [non-cancer; oral cancer           71-43-2
     endpoints].
    Boron....................................  7440-42-8
    Bromate..................................  7758-01-2
    1,3-Butadiene............................  106-99-0
    Cadmium..................................  7440-43-9
    Chloral hydrate..........................  75-87-6
    Chloroethane.............................  75-00-3
    Chloroform...............................  67-66-3
    Dichloroacetic acid......................  79-43-6
    1,3-Dichloropropene......................  542-75-6
    Diesel emissions.........................  [N.A.]
    Ethylene glycol butyl ether..............  111-76-2
    Formaldehyde.............................  50-00-0
    Nitrobenzene.............................  98-95-3
    Pentachlorophenol........................  87-86-5
    Polychlorinated biphenyls (PCBs)--         1336-36-3
     [noncancer endpoints].
    Styrene..................................  100-42-5
    Tetrachloroethylene [``perc'']...........  127-18-4
    Tetrahydrofuran..........................  109-99-9
    Toxaphene................................  8001-35-2
    Trichloroethylene........................  79-01-6
    Vinyl acetate............................  108-05-4
    Vinyl chloride...........................  75-01-4
    ------------------------------------------------------------------------
    
        The reassessment of Lindane [CAS No. 58-89-9 ] announced in the 
    January 2, 1998 Federal Register notice has been postponed to begin in 
    FY 2000 pending results from an ongoing cancer study.
        The IRIS summaries and support documents for the substances listed 
    above will be provided on the IRIS web site at www.epa.gov/iris. This 
    publicly-available web site is EPA's primary location for IRIS 
    documents.
    
    Information Requested on New Assessments for FY 1999
    
        EPA will continue building and updating the IRIS data base. The 
    Agency recognizes that many of the assessments on IRIS need updating to 
    incorporate new scientific information and methodologies. Further, many 
    additional substances are candidates for adding to IRIS. However, due 
    to limited resources in the Agency to address the spectrum of needs, 
    EPA developed a list of priority substances for attention beginning in 
    FY 1999. The following list of substances are priorities for IRIS due 
    to one or more of the following reasons: (1) Agency statutory, 
    regulatory, or program implementation need; (2) new scientific 
    information or methodology is available that might significantly change 
    current IRIS information, (3) interest to other levels of government or 
    the public, (4) most of the scientific assessment work has been 
    completed while meeting other Agency requirements, and only a modest 
    additional effort will be needed to complete the review and 
    documentation for IRIS.
        The following IRIS health assessments have recently begun or will 
    be started in FY 1999, with completion expected between FY 2000 and FY 
    2001. It is for these substances that the Agency is primarily 
    requesting information from the public for consideration in the 
    assessment. Unless otherwise noted, noncancer and cancer endpoints will 
    be assessed for each substance. Where information is available, oral 
    reference doses, inhalation reference concentrations, and cancer unit 
    risks and slope factors will be developed.
    
    [[Page 68287]]
    
    
    
    ------------------------------------------------------------------------
                       Name                               CAS No.
    ------------------------------------------------------------------------
    Acetaldehyde.............................  75-07-0
    Acetone..................................  67-64-1
    Ammonium perchlorate [and associated       7790-98-9
     salts].
    Benzo[a]pyrene...........................  50-32-8
    Chlorine dioxide.........................  10049-04-4
    Chlorite (sodium salts)..................  7758-19-2
    Chloroprene..............................  126-99-8
    Copper...................................  7440-50-8
    Cyclohexane..............................  110-82-7
    Di(2-ethylhexyl)phthalate................  117-81-7
    Diflubenzuron............................  35367-38-5
    Ethylbenzene.............................  100-41-4
    Ethylene oxide...........................  75-21-8
    Hexachlorocyclopentadiene................  77-47-4
    Isopropanol..............................  67-63-0
    Methyl chloride..........................  74-87-3
    Methyl isobutyl ketone (MIBK)............  108-10-1
    Methyl tert-butyl ether (MTBE)...........  1634-04-4
    Nickel (various).........................  7440-02-0
    Pendimethalin............................  40487-42-1
    Phenol...................................  108-95-2
    Quinoline................................  91-22-5
    Silica (quartz)..........................  14808-60-7
    Trichlopyr...............................  55335-06-3
    Uranium (natural)........................  7440-61-1
    Xylenes..................................  1330-20-7
    Zinc and compounds.......................  7440-66-6
    ------------------------------------------------------------------------
    
        In addition to Benzo[a]pyrene, EPA will also be initiating in FY 
    1999 a literature review on health effects of other polynuclear 
    aromatic hydrocarbons (PAHs). EPA welcomes scientific information from 
    the public on health effects of PAHs. Additional health assessments on 
    this class of chemicals will commence in FY 2000.
        Follow-up annual Federal Register notices will address new starts 
    for subsequent fiscal years. In the future, these notices will include 
    chemical substances selected for assessment or reassessment under EPA's 
    new guidelines for carcinogen risk assessment that are also planned for 
    inclusion in IRIS (64 FR 32799, June 25, 1996).
    
    Submission of Information
    
        The IRIS program is providing an opportunity for public involvement 
    on new assessments starting in FY 1999. While EPA conducts a thorough 
    literature search for each chemical substance, there may be other 
    articles or unpublished studies we are not aware of. We would greatly 
    appreciate receiving scientific information from the public during the 
    information gathering stage for the list of ``new assessments'' listed 
    above. Interested persons should provide scientific comments, analyses, 
    studies, and other pertinent scientific information. The most useful 
    documents for EPA are unpublished studies or other primary technical 
    sources that we may not otherwise obtain through open literature 
    searches. Also note that if you have submitted certain information 
    previously then there is no need to resubmit that information. 
    Information from the public is being solicited for 60 days via this 
    notice.
        Similar to the process described in the January 2, 1998 Federal 
    Register notice, submissions will be handled in a three-step process:
        1. First, you should simply provide a list (submission inventory), 
    briefly identifying all the information you wish to submit to the IRIS 
    Submission Desk. The list should specify by name and CAS (Chemical 
    Abstract Service) registry number the chemical substance(s) to which 
    the information pertains, state the type of assessment that is being 
    addressed (e.g., carcinogenicity), and describe briefly the information 
    being submitted for consideration. Where possible, documents should be 
    listed in scientific citation format, that is, author(s), title, 
    journal, and date. Your cover letter should state that the 
    correspondence is an IRIS Submission, describe in general terms the 
    purpose of the submission, and include names, addresses, and telephone 
    numbers of persons to contact for additional information on the 
    submission. Mail three copies of the submittal to the IRIS Submission 
    Desk, NCEA (MS-105), U.S. Environmental Protection Agency, 26 Martin 
    Luther King Drive, Cincinnati, OH 45268.
        Alternatively, you may submit the submission inventory and cover 
    letter electronically to IRIS.comments@epa.gov. Electronic information 
    must be submitted in WordPerfect or as an ASCII file. Information will 
    also be accepted on 3.5'' floppy disks. All information in electronic 
    form must be identified as an IRIS Submission.
        2. In the second step, EPA will compare the submission inventory to 
    existing files and identify the information that should be submitted. 
    This step will help prevent an influx of duplicative information. You 
    will receive notification requesting full submission of the selected 
    material.
        3. In the third step, you should send in the information requested 
    by EPA within 30 days to ensure that EPA can consider it in the 
    assessment. Submittals should include a cover letter addressing all of 
    the points in item 1 above. In addition, when you submit results of new 
    health effects studies concerning existing substances on IRIS, you 
    should include a specific explanation of how and why the study results 
    could change the information in IRIS.
        Please send three copies, at least one of which should be unbound, 
    to the IRIS Submission Desk, NCEA (MS-105), U.S. Environmental 
    Protection Agency, 26 Martin Luther King Drive, Cincinnati, OH 45268. 
    The IRIS Submission Desk will acknowledge receipt of your information.
        Confidential Business Information (CBI) should not be submitted to 
    the IRIS Submission Desk. CBI must be submitted to the appropriate EPA 
    Office via established procedures for submission of CBI (see 40 CFR, 
    Part 2, Subpart B). If you believe that a CBI submission contains 
    information with implications for IRIS, please note that in the cover 
    letter accompanying the submission to the appropriate office.
        You may also request to augment your submission with a scientific 
    briefing to EPA staff. Such requests should be made directly to Amy 
    Mills, IRIS Program Manager (Addressees).
    
        Dated: December 3, 1998.
    William H. Farland,
    Director, National Center for Environmental Assessment.
    [FR Doc. 98-32892 Filed 12-9-98; 8:45 am]
    BILLING CODE 6560-50-P
    
    
    

Document Information

Published:
12/10/1998
Department:
Environmental Protection Agency
Entry Type:
Notice
Action:
Notice; Announcement of IRIS 1999 Program and request for scientific information on chronic health effects of chemical substances.
Document Number:
98-32892
Dates:
Please submit information in response to this Notice by February 12, 1999.
Pages:
68285-68287 (3 pages)
Docket Numbers:
FRL-6200-3
PDF File:
98-32892.pdf